Before revision: It is marketed as a treatment for fatigue in multiple sclerosis (MS) .
After revision: , although in the 1950s multiple sclerosis was believed to be an alergic condition and Prokarin was developed as a treatment for the conditionIt is marketed as a treatment for fatigue in multiple sclerosis (MS) .